[On the development of blood coagulation disorders in pregnancy interruption. VI].
D000022:Abortion, Spontaneous / Q000150:complications*; D000328:Adult; D000933:Antifibrinolytic Agents / Q000032:analysis; D001778:Blood Coagulation Disorders / Q000209:etiology*; D003656:Decidua / Q000201:enzymology; D005321:Extraembryonic Membranes / Q000201:enzymology; D005260:Female; D005343:Fibrinolytic Agents / Q000032:analysis; D006801:Humans; D009130:Muscle, Smooth / Q000201:enzymology; D010770:Phosphotransferases / Q000032:analysis; D011247:Pregnancy; D013925:Thromboplastin / Q000032:analysis; D014599:Uterus / Q000201:enzymology
D000933:Antifibrinolytic Agents; D005343:Fibrinolytic Agents; D013925:Thromboplastin; D010770:Phosphotransferases
Uber die Entstehung von Blutgerinnungsstörungen bei der Schwangerschaftsunterbrechung. VI.